Capital Advisors Ltd’s Eli Lilly LLY Stock Holding History

Capital Advisors Ltd’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43M	Buy	1,191 +25	+2%	+$25.5K	0.14%	97
2026 Q1	$1.07M	Sell	1,166 -79	-6%	-$80.1K	0.12%	114
2025 Q4	$1.34M	Sell	1,245 -72	-5%	-$68.8K	0.15%	92
2025 Q3	$1M	Sell	1,317 -31	-2%	-$23.1K	0.11%	111
2025 Q2	$1.05M	Buy	1,348 +40	+3%	+$31.1K	0.13%	97
2025 Q1	$1.08M	Sell	1,308 -10	-0.8%	-$8.32K	0.14%	93
2024 Q4	$1.02M	Sell	1,318 -114	-8%	-$94.4K	0.13%	96
2024 Q3	$1.27M	Buy	1,432 +28	+2%	+$25.2K	0.16%	81
2024 Q2	$1.27M	Buy	1,404 +42	+3%	+$33.6K	0.17%	80
2024 Q1	$1.06M	Buy	1,362 +15	+1%	+$10.7K	0.14%	96
2023 Q4	$785K	Hold	1,347	–	–	0.11%	110
2023 Q3	$723K	Buy	1,347 +45	+3%	+$23.2K	0.11%	113
2023 Q2	$611K	Buy	1,302 +617	+90%	+$259K	0.09%	128
2023 Q1	$235K	Sell	685 -488	-42%	-$165K	0.04%	212
2022 Q4	$241K	Buy	1,173 +538	+85%	+$191K	0.04%	207
2022 Q3	$205K	Buy	635 +18	+3%	+$5.7K	0.04%	222
2022 Q2	$200K	Buy	617 +12	+2%	+$3.6K	0.04%	229
2022 Q1	$173K	Buy	605 +8	+1%	+$2.06K	0.03%	253
2021 Q4	$165K	Buy	597 +54	+10%	+$13.7K	0.03%	245
2021 Q3	$125K	Hold	543	–	–	0.02%	257
2021 Q2	$125K	Hold	543	–	–	0.02%	244
2021 Q1	$101K	Hold	543	–	–	0.02%	240
2020 Q4	$92K	Hold	543	–	–	0.02%	231
2020 Q3	$80K	Hold	543	–	–	0.02%	237
2020 Q2	$89K	Hold	543	–	–	0.02%	227
2020 Q1	$75K	Hold	543	–	–	0.02%	227
2019 Q4	$71K	Hold	543	–	–	0.02%	240
2019 Q3	$61K	Sell	543 -405	-43%	-$45.1K	0.02%	244
2019 Q2	$105K	Sell	948 -3,713	-80%	-$437K	0.03%	205
2019 Q1	$605K	Hold	4,661	–	–	0.16%	82
2018 Q4	$539K	Hold	4,661	–	–	0.16%	90
2018 Q3	$500K	Hold	4,661	–	–	0.14%	88
2018 Q2	$398K	Hold	4,661	–	–	0.12%	90
2018 Q1	$361K	Hold	4,661	–	–	0.12%	94
2017 Q4	$394K	Hold	4,661	–	–	0.13%	86
2017 Q3	$399K	Hold	4,661	–	–	0.14%	82
2017 Q2	$384K	Hold	4,661	–	–	0.14%	84
2017 Q1	$392K	Hold	4,661	–	–	0.15%	81
2016 Q4	$343K	Hold	4,661	–	–	0.14%	84
2016 Q3	$374K	Hold	4,661	–	–	0.16%	74
2016 Q2	$367K	Hold	4,661	–	–	0.17%	75
2016 Q1	$336K	Hold	4,661	–	–	0.17%	72
2015 Q4	$393K	Hold	4,661	–	–	0.2%	68
2015 Q3	$390K	Hold	4,661	–	–	0.22%	64
2015 Q2	$389K	Buy	4,661 +138	+3%	+$10.5K	0.2%	66
2015 Q1	$329K	Hold	4,523	–	–	0.17%	75
2014 Q4	$312K	Buy	4,523 +1	+0%	+$67	0.17%	72
2014 Q3	$293K	Sell	4,522 -1	-0%	-$63	0.17%	72
2014 Q2	$281K	Hold	4,523	–	–	0.16%	76
2014 Q1	$266K	Buy	4,523 +3,439	+317%	+$192K	0.16%	76
2013 Q4	$55K	Buy	+1,084	New	+$54.3K	0.04%	140

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Capital Advisors Ltd's LLY Position: Q2 2026 in Review

Capital Advisors Ltd increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $25.5K and bringing the position to 1,191 shares worth $1.43M. The position accounts for 0.14% of the portfolio, ranked #97.

Capital Advisors Ltd first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 1,719 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Capital Advisors Ltd held 1,191 shares of Eli Lilly worth $1.43M as of Q2 2026.
Capital Advisors Ltd bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
Eli Lilly made up 0.14% of Capital Advisors Ltd's portfolio in Q2 2026, its #97 holding.
Capital Advisors Ltd first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
1,719 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.